Profile
Mark D.
Rahn is currently a Director at Bioxydyn Ltd., Renephra Ltd., and APIS Assay Technologies Ltd. He is also a Partner at MTI Partners Ltd. Previously, he held positions as a Non-Executive Director at Arvia Technology Ltd. and as a Director at Cable Sense Ltd.
Mark D. Rahn active positions
| Companies | Position | Start |
|---|---|---|
MTI Partners Ltd.
MTI Partners Ltd. Investment ManagersFinance MTI Partners invests in companies located in Europe. The firm targets companies operating in the fields of health technology, net zero, digital and 3rd economy sectors. It provides financing for growth stage capital requirements. | Private Equity Investor | 2010-05-09 |
Bioxydyn Ltd.
Bioxydyn Ltd. Medical/Nursing ServicesHealth Services Provides groundbreaking MRI applications and imaging CRO services | Director/Board Member | 2011-06-26 |
APIS Assay Technologies Ltd.
APIS Assay Technologies Ltd. BiotechnologyHealth Technology Engages in research & development on biomarker-based diagnostic assays, targeting oncology, inflammatory, autoimmune, infectious disease and inherited disease areas | Director/Board Member | - |
Former positions of Mark D. Rahn
| Companies | Position | End |
|---|---|---|
Cable Sense Ltd.
Cable Sense Ltd. Miscellaneous Commercial ServicesCommercial Services Provides mapping and monitoring of structured cabling systems | Director/Board Member | - |
Renephra Ltd.
Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Develops medical devices | Director/Board Member | - |
Arvia Technology Ltd.
Arvia Technology Ltd. General GovernmentGovernment Provides water treatment and conservation technology and solutions | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MTI Partners Ltd.
MTI Partners Ltd. Investment ManagersFinance MTI Partners invests in companies located in Europe. The firm targets companies operating in the fields of health technology, net zero, digital and 3rd economy sectors. It provides financing for growth stage capital requirements. | Finance |
Arvia Technology Ltd.
Arvia Technology Ltd. General GovernmentGovernment Provides water treatment and conservation technology and solutions | Government |
Cable Sense Ltd.
Cable Sense Ltd. Miscellaneous Commercial ServicesCommercial Services Provides mapping and monitoring of structured cabling systems | Commercial Services |
Bioxydyn Ltd.
Bioxydyn Ltd. Medical/Nursing ServicesHealth Services Provides groundbreaking MRI applications and imaging CRO services | Health Services |
Renephra Ltd.
Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Develops medical devices | Commercial Services |
APIS Assay Technologies Ltd.
APIS Assay Technologies Ltd. BiotechnologyHealth Technology Engages in research & development on biomarker-based diagnostic assays, targeting oncology, inflammatory, autoimmune, infectious disease and inherited disease areas | Health Technology |
- Stock Market
- Insiders
- Mark D. Rahn
















